Doctor Patrick Foong
School of Law
I have taught law for many years in different countries and the last twelve years, in the Australasian region. I have taught at undergraduate and postgraduate courses including LLB and LLM. I also supervise HDR students. I have extensive experience in designing curriculum, setting assessments and moderation. I have consistently achieved excellent teaching evaluation and I was rated as outstanding lecturer by Swinburne university students. I am familiar with the use of modern technologies such as Blackboard, Collaborate, Echo 360 and Audacity software.
I am a member of the School’s Research and Higher Degree Committee. I am the sole author of my publications in peer- reviewed journals (national and international) and I am pursuing collaborative research. I publish in leading peer-reviewed journals, national (eg UNSW law journal) and international (eg Asian Bioethics Review). Both of my postgraduate qualifications are by research and they are in critical areas at the time. In my PhD thesis, I conducted analysis and made comparisons between the Australian regulatory regime on human embryonic stem cell research and the Malaysian regime against the backdrop of the regulatory theories of Professor Roger Brownsword (Kings College London, UK) and Professor John Braithwaite (Australian National University).
This information has been contributed by Doctor Foong.
- PhD University of Tasmania
- International Society for Stem Cell Research (ISSCR) (2012 - 2019)
Organisational Unit (School / Division)
- School of Law
|Phone:||(02) 9685 9217|
PLEASE NOTE: obtaining information from this Directory must be for the legitimate purposes of doing business with and within Western Sydney University, and must not be used for unsolicited bulk e-mailing (spamming) or similar purposes.
Previous Teaching Areas
- 200011 Contracts, 2020
- 200295 Bioethics, 2019
- 200813 Civil Procedure and Arbitration, 2019
- 200957 Bioethics in Perspective, 2019
- Borsellino, G., Foong, C. and Allan, S. (2021), 'The regulation and governance of clinical trials : past and present considerations to ensure ethical treatment of human participants', Journal of Law and Medicine, vol 28 , pp 421 - 438.
- Foong, C. (2020), 'Regulating unproven stem cell interventions : how effective are the ISSCR guidelines?', Biotechnology Law Report, vol 39, no 3 , pp 196 - 203.
- Foong, C. (2019), 'Regulating human genome editing in Australia : overdue legislative review', Biotechnology Law Report, vol 38, no 1 .
- Foong, C. (2019), 'Ownership issues in autologous stem cell therapies', Eubios Journal of Asian and International Bioethics, vol 29, no 6 , pp 186 - 191.
- Foong, C. (2018), 'Stem cell tourism : addressing the challenge of regulatory cosmopolitanism', Eubios Journal of Asian and International Bioethics, vol 28, no 4 , pp 118 - 127.
- Foong, C. (2018), 'Stemming the tide of unproven autologous stem cell therapies in Australia', University of New South Wales Law Journal, vol 3 .
- Foong, C. (2017), 'Is human embryonic stem cell (HESC) research still necessary today?', Asian Bioethics Review, vol 9, no 1-2 , pp 33 - 44.
- Foong, C. (2016), 'The regulatory regime for the use of embryos in research : Braithwaite's theory of responsive regulation', Eubios Journal of Asian and International Bioethics, vol 26, no 5 , pp 200 - 206.
- Foong, C. (2016), 'Regulating human embryonic stem cell (HESC) research in Australia : Brownsword's regulatory challenges', Curtin Law and Taxation Review, vol 3 , pp 131 - 170.
- Foong, C. (2014), 'Addressing exploitation of women in therapeutic cloning/somatic cell nuclear transfer (SCNT) research through strict legal oversight in Australia', Asian Bioethics Review, vol 6, no 4 , pp 359 - 370.
- Foong, C. (2012), 'The need to pay egg donors for use in therapeutic cloning/Somatic Cell Nuclear Transfer (SCNT) research', Legal Issues in Business, vol 14 , pp 3 - 8.
- Foong, C. (2012), 'The regulatory regime for human embryonic stem cell (HESC) research in Malaysia : a critique', Journal Undang-Udang dan Masyarakat: Malaysian Journal of Law and Society, vol 16 , pp 55 - 68.
- Foong, C. (2011), 'Human embryonic stem cell (HESC) research in Malaysia : multi-faith perspectives', Asian Bioethics Review, vol 3, no 3 , pp 182 - 206.
I am a member of the School’s Research and Higher Degree Committee. My PhD topic was in the regulation of the controversial embryonic stem cell research. My current research interest is in the ethics and law of emerging biotechnologies eg organoid technology, human gene editing (eg CRISPR-Cas9), sheefs and others.
I publish in top international bioethics law journals (appear in Bioethics Research Library of Georgetown University's and Google Scholar's list of top bioethics journals) and I am a regular contributor to the Asian Bioethics Review (publication of the Centre for Biomedical Ethics at the National University of Singapore, a collaborating centre on bioethics of the World Health Organisation).
Each year, I present at the annual conference of International Society for Stem Cell Research (ISSCR), the largest stem cell organisation in the world as well as other conferences (national and international).
I have also contributed to The Conversation and they have been captured by the media. My research should be useful to scientists, doctors, patients and their advocates/ carers, regulators, policy-makers, researchers and all concerned citizens, national as well as international.
This information has been contributed by Doctor Foong.
|Description:||The Emergence of iBlastoids: Time to update the Law?|
|Description:||What is the law on iBlastoids?|
|Description:||Is it ethical to make human blastocysts in a lab?|
|Description:||A class action suit against an Australian IVF provider is a reminder that IVF is a huge industry|
|Description:||Class Action Lawsuit: Has Monash IVF breached its Legal Duty of Care?|
|Description:||California's Proposition 14: A Short in the Arm for Stem Cell Research|
|Description:||The California Institute for Regenerative Medicine gets a Second Lease of Life|
|Description:||New Study on CRISPR: The Stake of Unintended Consequences in Embryos|
|Description:||Patients with Neurological Diseases seeking Stem Cell Treatments|
|Description:||Regenerative Clinics: Strong Language from FDA|
|Description:||Covid-19: Should We Deliberately Infect Volunteers?|
|Description:||Unproven Stem Cell Therapies, and now, Strong Words from FDA|
|Description:||Stem Cells Touted for Coronavirus Treatments|
|Description:||Unscrupulous scammers are selling stem cell therapies for Covid-19|
|Description:||Ethical Issues Surrounding Egg Donation in Genome Editing|
|Description:||Human Genome Editing: What about the Protection of Egg Donors in Research?|
|Description:||How should chimeric embryo research be regulated?|
|Description:||Designing Your Own Child|
|Description:||Stemming The Tide of Unproven Autologous Stem Cell Therapies in Australia|
|Description:||The brave new world of human genome editing: an Australian perspective|
|Description:||Fertility tourism: Australians travelling to US to have ???designer babies???|
|Description:||Right to try bills passed in US: more harm than good?|
|Description:||Untested stem cell therapies finally drawing attention of Australian regulators|
|Description:||Confronting unproven stem cell treatments in Australia: the new regulation|
|Description:||The Hwang Dilemma: Exploitation of Women in SCNT, 2009|
|Title:||The Healthy Mummy|
|Description:||Should We Rethink our Position on Embryo Research? 2017|
|Description:||What Australia needs to do to protect consumers from untested stem-cell treatments August 9, 2016|
|Description:||Destroying research embryos within 14 days limits chance of medical breakthroughs|